Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,165 | 459 | 98.6% |
| Education | $98.34 | 6 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $990.56 | 80 | $0 (2024) |
| PFIZER INC. | $760.23 | 51 | $0 (2024) |
| Amgen Inc. | $589.34 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $546.85 | 35 | $0 (2024) |
| ABBVIE INC. | $478.10 | 24 | $0 (2024) |
| Lilly USA, LLC | $461.81 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $412.39 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $348.90 | 19 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $280.56 | 17 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $228.61 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $942.09 | 42 | AstraZeneca Pharmaceuticals LP ($167.78) |
| 2023 | $630.98 | 39 | Novo Nordisk Inc ($145.99) |
| 2022 | $600.01 | 41 | Novo Nordisk Inc ($135.93) |
| 2021 | $871.18 | 58 | Lilly USA, LLC ($135.29) |
| 2020 | $710.44 | 46 | PFIZER INC. ($84.78) |
| 2019 | $1,146 | 75 | PFIZER INC. ($239.43) |
| 2018 | $1,198 | 84 | Amgen Inc. ($161.52) |
| 2017 | $1,164 | 80 | Novo Nordisk Inc ($170.46) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Obesity | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardio-renal | ||||||
| 08/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Biological | ||||||
| 08/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $60.95 | General |
| Category: Hematology | ||||||
| 07/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardio-renal | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 06/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: PAIN | ||||||
| 06/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,748 | 2,083 | $311,660 | $80,534 |
| 2022 | 20 | 2,215 | 2,610 | $329,370 | $120,156 |
| 2021 | 26 | 2,588 | 3,170 | $372,481 | $129,745 |
| 2020 | 22 | 2,504 | 2,958 | $345,255 | $202,033 |
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 451 | 696 | $104,400 | $32,011 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 426 | 426 | $104,350 | $20,539 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 232 | $25,520 | $10,031 | 39.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 44 | 54 | $16,200 | $4,138 | 25.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 75 | 85 | $5,625 | $3,759 | 66.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 399 | 399 | $39,900 | $3,380 | 8.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,150 | $2,050 | 49.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 22 | $5,500 | $1,613 | 29.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 57 | 57 | $1,710 | $1,047 | 61.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 57 | 57 | $1,710 | $1,047 | 61.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 14 | $840.00 | $620.76 | 73.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 27 | $1,755 | $298.22 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 462 | 764 | $114,750 | $34,785 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 389 | 389 | $77,800 | $20,980 | 27.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 244 | 249 | $17,430 | $17,056 | 97.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 189 | $20,790 | $8,648 | 41.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 258 | 263 | $10,470 | $7,871 | 75.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 317 | 319 | $31,900 | $5,667 | 17.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 109 | 135 | $6,750 | $4,310 | 63.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $4,500 | $4,171 | 92.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 57 | 65 | $19,500 | $4,058 | 20.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 13 | 13 | $3,250 | $3,176 | 97.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $5,500 | $2,423 | 44.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,600 | $1,769 | 68.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 37 | 37 | $1,450 | $1,111 | 76.6% |
About Dr. Sandeep Mann, M.D
Dr. Sandeep Mann, M.D is a Internal Medicine healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891776761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandeep Mann, M.D has received a total of $7,264 in payments from pharmaceutical and medical device companies, with $942.09 received in 2024. These payments were reported across 465 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,165).
As a Medicare-enrolled provider, Mann has provided services to 9,055 Medicare beneficiaries, totaling 10,821 services with total Medicare billing of $532,468. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dover, DE
- Active Since 11/08/2005
- Last Updated 12/28/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1891776761
Products in Payments
- FARXIGA (Drug) $405.18
- Ozempic (Drug) $391.54
- XARELTO (Drug) $299.56
- MYRBETRIQ (Drug) $222.63
- TRULICITY (Drug) $214.79
- Creon (Drug) $198.85
- ELIQUIS (Drug) $195.14
- Aimovig (Biological) $191.09
- ENTRESTO (Drug) $176.59
- Vascepa (Drug) $175.61
- CHANTIX (Drug) $174.49
- Prolia (Biological) $145.54
- STIOLTO RESPIMAT (Drug) $137.29
- Tresiba (Drug) $137.00
- Rybelsus (Drug) $131.15
- EUCRISA (Drug) $129.39
- UBRELVY (Drug) $126.97
- NURTEC ODT (Drug) $110.36
- ACCRUFER (Drug) $106.49
- Repatha (Biological) $105.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dover
Bhavin Dave, Md, MD
Internal Medicine — Payments: $52,075
Nitish Sharma, M.d, M.D
Internal Medicine — Payments: $23,481
Dr. Natwarlal Ramani, Md, MD
Internal Medicine — Payments: $10,598
Dr. Gregory Imbrie, Md, MD
Internal Medicine — Payments: $10,249
Theodore Conrad Tan, M.d, M.D
Internal Medicine — Payments: $7,411
Dr. Abimbola Osunkoya, M.d, M.r., C.o.g, M.D, M.R., C.O.G
Internal Medicine — Payments: $6,886